Oramed Pharmaceuticals Inc. Forecast, price target & analysts
$4.20
3.45%
Nasdaq, Oct 20, 01:49 pm EDT.
Market open.
Index
Industry
Oramed Pharmaceuticals Inc. Target price 2026 - Analyst rating & recommendation
Powered by
Oramed Pharmaceuticals Inc. Classifications & Recommendation
Hold
50%
Sell
50%
Oramed Pharmaceuticals Inc. Price Target
| Target Price | $7.14 |
| Price | $4.06 |
| Potential | |
| Number of Estimates | 3 |
| 3 Analysts have issued a price target Oramed Pharmaceuticals Inc. 2027 . The average Oramed Pharmaceuticals Inc. target price is $7.14. This is higher than the current stock price. The highest price target is , the lowest is . | |
| A rating was issued by 6 analysts: 0 Analysts recommend Oramed Pharmaceuticals Inc. to buy, 3 to hold and 3 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Oramed Pharmaceuticals Inc. stock has an average upside potential 2027 of . Most analysts recommend the Oramed Pharmaceuticals Inc. stock at Sell or hold. |
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
Create a premium account to unlock analyst estimates.
Learn more
Powered by
Quarter
Annually
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | ??? | ??? |
| ??? | ??? | |
| P/E | ??? |
3 Analysts have issued a Oramed Pharmaceuticals Inc. forecast for earnings per share. The average Oramed Pharmaceuticals Inc. EPS is
. This is than earnings per share in the financial year 2025. The highest EPS forecast is , the lowest is .This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2025 | $1.51 | 421.28% |
|---|---|---|
| 2026 | ||
P/E ratio
| Current | 0.98 | 124.69% |
|---|---|---|
| 2026 | ||
Oramed Pharmaceuticals Inc....
Current Oramed Pharmaceuticals Inc. Upgrades & Downgrades
Create a Premium account to unlock Upgrades/Downgrades.
Learn more
| Analyst | Rating | Action | Date |
|---|---|---|---|
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| Analyst Rating | Date |
|---|---|
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
